Recent Press Releases

Amgen Announces 2014 Third Quarter Dividend

THOUSAND OAKS, Calif., July 25, 2014 /PRNewswire/ -- Amgen (NASDAQ: AMGN) announced that its Board of Directo

European CHMP Adopts Positive Opinion for Gilead's Zydelig® (idelalisib) for the Treatment of Chronic Lymphocytic Leukemia and Follicular Lymphoma

FOSTER CITY, Calif.--Jul. 25, 2014-- Gilead Sciences, Inc. (NASDAQ:GILD) today announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European...

Zerenex(TM) (Ferric Citrate) Long-Term Phase 3 Study Results Published in the Journal of the American Society of Nephrology

NEW YORK -- Keryx Biopharmaceuticals, Inc. (KERX) (the "Company") announced the publication of results from the long-term, randomized, active control Phase 3 study of Zerenex (ferric...

Ultragenyx Pharmaceuticals (RARE) Appoints Sunil Agarwal, M.D. As Chief Medical Officer And Senior Vice President

NOVATO, Calif., July 23, 2014 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (Nasdaq:RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare...

Innocoll AG Announces Pricing of Initial Public Offering

ATHLONE, Ireland, July 25, 2014 -- Innocoll AG (the "Company"), a global, commercial-stage, specialty pharmaceutical company that develops and manufactures a range of pharmaceutical...

AuraSense Therapeutics Appoints Biotechnology Veteran David S. Snyder As Chief Financial Officer

SKOKIE, Ill., July 23, 2014 /PRNewswire/ -- AuraSense Therapeutics, the pioneer in developing spherical nucleic acid (SNA) constructs as gene regulatory and immunotherapeutic agents, announced today...

Zenith Epigenetics Appoints Julie Cherrington As President And CEO

CALGARY, July 23, 2014 /PRNewswire/ - Zenith Epigenetics Corp. ("Zenith" or the "Company") today announced that it has appointed Julie Cherrington PhD to act as the President and...

ConMed Corporation (CNMD) Announces Leadership Transition

Cerus Corporation Secures $30 Million Growth Capital Credit Facility From Oxford Finance Joseph Corasanti Steps Down as CEO Founder Gene Corasanti Retires Independent Board Member Curt Hartman...

BioDelivery Sciences International (BDSI) Appoints Charles J. Bramlage And Dr. Barry I. Feinberg To Its Board Of Directors - 7/22

RALEIGH, N.C., July 22, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (BDSI) (NASDAQ: BDSI) announced that its Board of Directors has appointed Charles J. (Chuck) Bramlage and Dr....

Ocular Therapeutix Prices Initial Public Offering

BEDFORD, Mass.--Ocular Therapeutix, a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, announced today the...

Alliqua Biomedical (ALQA) Announces Changes to Its Board Of Directors - 7/22

LANGHORNE, Pa., July 22, 2014 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"), today announced the appointment of Andrew Africk and Gary...

Clarus Therapeutics Expands Board of Directors With Appointment Of Two Pharmaceutical Industry Veterans - 7/22

NORTHBROOK, Ill., July 21, 2014 (GLOBE NEWSWIRE) -- Clarus Therapeutics, Inc., a men's health specialty pharmaceutical company focused on the development and commercialization of REXTORO®, an...

Viamet Pharmaceuticals Announces Appointment Of Amir Tavakkol, Ph.D., As Chief Development Officer - 7/22

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Viamet Pharmaceuticals, Inc. today announced the appointment of Amir Tavakkol, Ph.D., as Chief Development Officer. Dr. Tavakkol brings over 25 years of...

Agena Biosciences Appoints Peter Dansky As Chief Executive Officer - 7/22

SAN DIEGO, July 21, 2014 /PRNewswire/ -- Agena Bioscience, Inc., the provider of the MassARRAY® System for genetic analysis, announced today that Peter Dansky has joined the company as its Chief...

Blueprint Medicines Appoints Jeffrey Albers As Chief Executive Officer

Blueprint Medicines Appoints Jeffrey Albers As Chief Executive Officer CAMBRIDGE, Mass., July 24, 2014 /PRNewswire/ -- Blueprint Medicines (Blueprint), a leader in discovering highly selective kinase...

Sysmex Corporation Appoints U.S. Subsidiary CEO John Kershaw To Executive Officer

Sysmex Corporation Appoints U.S. Subsidiary CEO John Kershaw To Executive Officer LINCOLNSHIRE, Ill., July 23, 2014 /PRNewswire/ -- Sysmex America, Inc., the United States subsidiary for Sysmex...

Cypher Genomics Announces The Appointment Of Adam Simpson As President And COO To Advance Transformative Genome Interpretation Technology

Cypher Genomics Announces The Appointment Of Adam Simpson As President And COO To Advance Transformative Genome Interpretation Technology SAN DIEGO, July 24, 2014 /PRNewswire/ -- Cypher Genomics,...

Juventas Therapeutics, Inc. Strengthens Leadership Team By Adding Two Industry Veterans

Juventas Therapeutics, Inc. Strengthens Leadership Team By Adding Two Industry Veterans CLEVELAND, July 23, 2014 /PRNewswire-USNewswire/ -- Juventas Therapeutics, a clinical-stage biotechnology...

Cypher Genomics Appoints To The Board Of Directors, Henry Nordhoff As Executive Chairman And Herbert Boyer And Andrew Von Eschenbach As Directors

Cypher Genomics Appoints To The Board Of Directors, Henry Nordhoff As Executive Chairman And Herbert Boyer And Andrew Von Eschenbach As Directors SAN DIEGO, July 24, 2014 /PRNewswire/ -- Cypher...